Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi's Laboratories rises to record high on quarterly profit jump

BUZZ-India's Divi's Laboratories rises to record high on quarterly profit jump

** Shares of India's Divi's Laboratories DIVI.NS rise 4.3% to a record high of 8,404.50 rupees

** The drugmaker on Saturday reported first-quarter profit up 65.5% y/y; revenue from operations up 27.8% y/y

** Citi ("buy") revises TP up to 11,700 rupees from 9,450 rupees, says EBITDA margins expanded 72% y/y due to strong custom synthesis business

** Jefferies ("buy") revises TP up to 10,200 rupees from 7,950 rupees, says company outlook remains strong with "best in class pipeline"

** Morgan Stanley ("overweight") revises TP up to 9,111 rupees from 7,904 rupees

** Brokerage expects strong first-quarter and H2FY27 project ramp-ups to drive ~20% revenue growth

** DIVI on avg rated "hold"; median PT is 6,921 rupees - LSEG-compiled data

** Stock up 31.5%, YTD



(Reporting by Abhirami G in Bengaluru)

((abhirami.g@thomsonreuters.com))

Recent news on Divi's Laboratories

See all news